← FDA Drug Approvals (Drugs@FDA)

MEKINIST

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2023-03-16

Drug application

FDA Application #

NDA217513

Application type

New Drug Application

Brand name

MEKINIST

Generic name

TRAMETINIB

Active ingredients

TRAMETINIB

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

NOVARTIS

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2023-03-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown